Skip to main content

Table 2 UDVA evolution up to three months after LASEK with MMC of 394 myopic eyes treated with Allegretto, Esiris and Technolas excimer lasers

From: Myopic Laser-Assisted Subepithelial Keratectomy (LASEK) outcomes using three different excimer laser platforms: a retrospective observational study

Parameter

Mean ± SD

Follow-up visit

ALLEGRETTO

ESIRIS

TECHNOLAS

P-valuea

Eyes

 

(n = 122)

(n = 135)

(n = 137)

 

UDVA (Decimal)

1 day

0.64 ± 0.33

0.63 ± 0.24

0.57 ± 0.21

0.2

1 week

0.72 ± 0.21

0.80 ± 0.24

0.81 ± 0.61

0.4

1 month

0.94 ± 0.23

0.92 ± 0.17

0.88 ± 0.19

0.07

3 months

1.11 ± 0.19

1.01 ± 0.21

0.98 ± 0.20

0.0001

UDVA (LogMAR)

1 day

0.29 ± 0.38

0.23 ± 0.20

0.27 ± 0.17

0.5

1 week

0.16 ± 0.15

0.12 ± 0.17

0.13 ± 0.17

0.4

1 month

0.04 ± 0.13

0.04 ± 0.10

0.06 ± 0.11

0.2

3 months

−0.03 ± 0.10

0.09 ± 0.11

0.01 ± 0.10

0.0001

  1. UDVA uncorrected distance visual acuity, SD standard deviation
  2. aFactorial ANOVA test